Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Atopic Dermatitis \(AD\)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT05882877
What this trial is testing

Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)

Who this might be right for
Atopic Dermatitis
Amgen 2,621
Large-scale testing (Phase 3)Looking for participantsNCT06850311
What this trial is testing

Herbal Ointment in Treating Atopic Dermatitis Topically

Who this might be right for
Atopic DermatitisAtopic Dermatitis (AD)Atopic Dermatitis (Eczema)+5 more
En Chu Kong Hospital 66
Testing effectiveness (Phase 2)Looking for participantsNCT06855745
What this trial is testing

Phase 2 Randomized Double-blind Study to Assess Topical Zabalafin Hydrogel Vs Vehicle in Mild to Moderate AD.

Who this might be right for
Atopic Dermatitis (Eczema)Atopic Dermatitis EczemaAtopic Dermatitis+3 more
Alphyn Biologics 72
Not applicableActive Not RecruitingNCT06415175
What this trial is testing

Study in Paediatric Patients With Atopic Dermatitis Treated With Dupilumab in Spain

Who this might be right for
Atopic Dermatitis
Sanofi 143
Testing effectiveness (Phase 2)Study completedNCT01927705
What this trial is testing

Safety and Efficacy of FURESTEM-AD Inj. in Patients With Moderately Subacute and Chronic Atopic Dermatitis (AD)

Who this might be right for
Atopic Dermatitis
Kang Stem Biotech Co., Ltd. 34
Testing effectiveness (Phase 2)Study completedNCT01359787
What this trial is testing

Efficacy and Safety of Different Concentrations of Mapracorat Ointment Over 4 Weeks in Atopic Dermatitis (AD)

Who this might be right for
Atopic DermatitisEczema
Bayer 197
Testing effectiveness (Phase 2)Study completedNCT04339985
What this trial is testing

Study to Evaluate Safety & Efficacy of Topical ATx201 OINTMENT in Adolescents and Adults With Mild to Moderate AD

Who this might be right for
Atopic Dermatitis
UNION therapeutics 220
Large-scale testing (Phase 3)Study completedNCT05704738
What this trial is testing

Evaluate Rocatinlimab (AMG 451) in Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)

Who this might be right for
Atopic Dermatitis
Amgen 532
Early research (Phase 1)Study completedNCT01850849
What this trial is testing

Safety, Tolerability and Pharmacokinetics in AD Subjects and Healthy Subjects of Cutaneous Application of LEO 39652 Cream

Who this might be right for
Atopic Dermatitis
LEO Pharma 23
Large-scale testing (Phase 3)Ended earlyNCT05732454
What this trial is testing

Learn About the Study Medicine Etrasimod in Adults With Moderate to Severe Atopic Dermatitis (AD) Who Have Already Tried Treatments Taken by Mouth or by Injection

Who this might be right for
Atopic DermatitisAtopic Dermatitis, UnspecifiedEczema+1 more
Pfizer 58
Testing effectiveness (Phase 2)Ended earlyNCT06881251
What this trial is testing

JNJ-95475939 in the Treatment of Participants With Moderate to Severe Atopic Dermatitis (AD)

Who this might be right for
Dermatitis, Atopic
Janssen Research & Development, LLC 256
Not applicableStudy completedNCT07333300
What this trial is testing

Exploratory Clinical Investigation on Neurosensory Responses Via EEG Headband in Adults With Mild to Moderate Atopic Dermatitis After Application of Marketed Product Compared With Placebo (Water Application).

Who this might be right for
Atopic Dermatitis (AD)
NovoBliss Research Pvt Ltd 20
Early research (Phase 1)Looking for participantsNCT07235384
What this trial is testing

A Phase 1/1b Study to Evaluate Safety, Tolerability and Pharmacokinetics of ZL-1503 in Healthy Volunteers and Participants With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis (AD)
Zai Lab (Shanghai) Co., Ltd. 84
Testing effectiveness (Phase 2)Study completedNCT05470114
What this trial is testing

A Multi-omics Disease Signature Trial in Adult Patients With Moderate to Severe AD

Who this might be right for
Atopic Dermatitis
LEO Pharma 13
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07810777
What this trial is testing

PRA-216 Atopic Dermatitis Safety and Efficacy Study

Who this might be right for
Atopic Dermatitis (AD)
Prana Therapies Inc 39
Large-scale testing (Phase 3)Active Not RecruitingNCT02612454
What this trial is testing

Study to Assess the Long-term Safety of Dupilumab Administered in Participants ≥6 Months to <18 Years of Age With Atopic Dermatitis (AD)

Who this might be right for
Atopic Dermatitis
Regeneron Pharmaceuticals 880
Large-scale testing (Phase 3)Study completedNCT05601882
What this trial is testing

Evaluate Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
AbbVie 920
Not applicableStudy completedNCT04541810
What this trial is testing

Oral Upadacitinib (RINVOQ) Tablets to Assess Adverse Events and Change in Disease Symptoms in Korean Participants With Moderate to Severe Active Rheumatoid Arthritis, Atopic Dermatitis, Ankylosing Spondylitis or Psoriatic Arthritis

Who this might be right for
Rheumatoid Arthritis (RA)Atopic Dermatitis (AD)Ankylosing Spondylitis (AS)+1 more
AbbVie 2,369
Early research (Phase 1)Enrolling By InvitationNCT06744569
What this trial is testing

A Phase I Clinical Trial to Evaluate CU-10101 Unguent

Who this might be right for
Atopic Dermatitis
Cutia Therapeutics（Wuxi）Co.,Ltd 64
Testing effectiveness (Phase 2)Study completedNCT03151148
What this trial is testing

Targeted Microbiome Transplant in Atopic Dermatitis

Who this might be right for
Atopic Dermatitis (AD)
National Institute of Allergy and Infectious Diseases (NIAID) 54
Next Page